top of page
News


Important milestone - funding secured
Moroxite AB has successfully raised SEK 22 million— backed by current owners and a small number of selected new investors. This funding...
4 days ago


Moroxite advances to stage 2 of European Innovation Council's Accelerator Programme with Xerafuse™
Moroxite has successfully cleared Stage 1 of the EIC Accelerator programme for our innovative product, Xerafuse™. This bone mineral...
Apr 8


Moroxite F welcomes Marie Grey as Chief of Quality Assurance and Regulatory Affairs
Present key target in her role at Moroxite F is regulatory approval in US
Oct 24, 2024


Thesis support Moroxite F’s product concept
Dr. Markevičiūtė has shown that CaS/HA augmentation combined with systemic bisphosphonate could be superior to present techniques
Aug 23, 2024


Breakthrough study shows new bone formation with Moroxite F’s Biomodulation concept
A clinical feasibility study, conducted in collaboration with researchers from Sweden, Lithuania, Germany, and China, have yielded...
Mar 14, 2024


Secured funding
It is reassuring and gratifying for all of us at Moroxite F to have secured the funds to be able to continue working with strong progress
Jan 11, 2024


Moroxite F team wraps up study in spine segment – Results Coming Soon!
Moroxite F team comprising of CTO Deepak Raina and doctoral student Jintian Huang accompanied by Prof. Stefan Zwingenberger and his team...
Nov 1, 2023


Ethical approval granted for a randomized controlled trial in trochanteric fractures using Moroxite F’s FARE procedure
Assistant Professor Erdem Aras Sezgin at Aksaray University of Medicine, Department of Orthopedics and Traumatology, Turkey has on...
Sep 14, 2023


Introducing new Team members
We are delighted to introduce two talented professionals who have recently joined our team
May 5, 2023


Exciting research collaboration to test bio-modulation for enhanced implant anchorage
Our research group has collaborated with Prof. Ding to test the Fracture Anchorage and Regeneration concept in a pre-clinical setting...
Feb 9, 2023


EORS and International combined orthopedic research society joint meeting
TERM group at LU presented their work a the recently held EORS and International Combined Orthopedic Research Society joint meeting....
Jan 1, 2023


34orna 2022: Moroxite F CTO Deepak Raina named ‘34under34’ a future star in Skåne’s business community
The whole team at Moroxite F want to congratulate Deepak on this well-deserved recognition and testament to his work.
Nov 21, 2022


Moroxite F announces the appointment of Johan Tinnerholm as CEO
Moroxite F is a very exciting company built on groundbreaking research.
Oct 17, 2022


Invited talk by TERM group at LU at the Nordic Orthopedic Foundation's annual meeting
Researchers from TERM group at LU gave an invited talk on ‘A New Augmentation Method for Improved Screw Fixation in Fragile Bone With...
Sep 7, 2022


First proof-of-concept study published in Frontiers in Bioengineering and Biotechnology
The term group at LU has published the first proof-of-concept study describing Moroxite F AB groundbreaking implant fixation technology...
Mar 2, 2022


ALMI Invest invests SEK 4 million
Almi Invest is investing four million kronor in Moroxite F for developing a new treatment for osteoporosis. Fåhraeus Startup & Growth is...
Feb 18, 2022


Fåhraeus Startup & Growth invests in Moroxite F
Fåhraeus Startup & Growth fund invests six million Swedish crowns in Moroxite F.
Feb 16, 2022
bottom of page